Antibody-based therapy is advancing as a potential treatment for mucormycosis, a severe fungal infection with high mortality rates, especially in immunocompromised individuals.

Their paper, "A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response," was recently accepted and published in the Science Translational Medicine journal.

California: Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and those who have suffered severe trauma, such as burns ...

Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of ...

California [US], March 22 (ANI): Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and those who have suffered severe trauma ...

Mucormycosis, a severe fungal infection caused by Mucorales, poses a significant threat to people with weakened immune systems. It is particularly dangerous for patients with diabetes, cancer, or ...